| 1 |
Wang J, Zhang H, Zhang H, Fang H. Public health impact and cost-effectiveness of rotavirus vaccination in China: Comparison between private market provision and national immunization programs. Hum Vaccin Immunother 2022;18:2090162. [PMID: 35816415 DOI: 10.1080/21645515.2022.2090162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 2 |
Karakusevic A, Devaney P, Enstone A, Kanibir N, Hartwig S, Carias CDS. The burden of rotavirus-associated acute gastroenteritis in the elderly: assessment of the epidemiology in the context of universal childhood vaccination programs. Expert Rev Vaccines 2022;:1-12. [PMID: 35535677 DOI: 10.1080/14760584.2022.2066524] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Shelly A, Chakraborty D, Panda AK, Majumdar T. Riddle of Herd Immunity in SARS-CoV-2-Induced Viral Terrorism: Science to Society. COVID-19: Tackling Global Pandemics through Scientific and Social Tools 2022. [DOI: 10.1016/b978-0-323-85844-1.00005-2] [Reference Citation Analysis]
|
| 4 |
Mast TC, Heyman D, Dasbach E, Roberts C, Goveia MG, Finelli L. Planning for monitoring the introduction and effectiveness of new vaccines using real-word data and geospatial visualization: An example using rotavirus vaccines with potential application to SARS-CoV-2. Vaccine X 2021;7:100084. [PMID: 33521625 DOI: 10.1016/j.jvacx.2021.100084] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Shelly A, Gupta P, Ahuja R, Srichandan S, Meena J, Majumdar T. Impact of Microbiota: A Paradigm for Evolving Herd Immunity against Viral Diseases. Viruses 2020;12:E1150. [PMID: 33050511 DOI: 10.3390/v12101150] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 6 |
Shen J, Chen JJ, Zhang BM, Zhao J, Chen L, Ye QY, Ling QH, Chen YY, Zhong ZY, Huang QW. Baicalin Is Curative Against Rotavirus Damp Heat Diarrhea by Tuning Colonic Mucosal Barrier and Lung Immune Function. Dig Dis Sci 2020;65:2234-45. [PMID: 31802384 DOI: 10.1007/s10620-019-05977-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 7 |
de Lusignan S, Konstantara E, Joy M, Sherlock J, Hoang U, Coyle R, Ferreira F, Jones S, O'Brien SJ. Incidence of household transmission of acute gastroenteritis (AGE) in a primary care sentinel network (1992-2017): cross-sectional and retrospective cohort study protocol. BMJ Open 2018;8:e022524. [PMID: 30139907 DOI: 10.1136/bmjopen-2018-022524] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 8 |
Degiuseppe JI, Stupka JA. First assessment of all-cause acute diarrhoea and rotavirus-confirmed cases following massive vaccination in Argentina. Epidemiol Infect 2018;146:1948-54. [PMID: 30001762 DOI: 10.1017/S0950268818001954] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Bennett A, Bar-Zeev N, Cunliffe NA. Measuring indirect effects of rotavirus vaccine in low income countries. Vaccine 2016;34:4351-3. [PMID: 27443593 DOI: 10.1016/j.vaccine.2016.07.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 10 |
Czerkinsky C, Holmgren J. Vaccines against enteric infections for the developing world. Philos Trans R Soc Lond B Biol Sci 2015;370:20150142. [PMID: 25964464 DOI: 10.1098/rstb.2015.0142] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 11 |
Kang G, Tate JE, Parashar UD. Evaluation of rotavirus disease burden and vaccine effectiveness in India. Vaccine 2015;33:7143. [PMID: 26675194 DOI: 10.1016/j.vaccine.2015.08.092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
